InnovAge (INNV) vs Strata Critical Medical (SRTA)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
InnovAge (INNV) has outperformed Strata Critical Medical (SRTA) over the past year, gaining 74.5% versus a gain of 8.6%. Over five years, INNV leads with a +20.4% price change compared with -46.8% for SRTA. InnovAge is the larger company by market cap ($1.25 billion vs $407.3 million), about 3.1 times the size, while Strata Critical Medical is growing revenue faster (+34.3% vs +15.9%).
Strata Critical Medical converts more of its revenue into profit, with a net margin of 21.0% versus -0.3%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | INNV | SRTA |
|---|---|---|
| Share price | $9.16 | $4.56 |
| Market cap | $1.25B | $407.30M |
| 1-day change | +2.81% | -5.59% |
| YTD return | +76.49% | -5.20% |
| 1-year return | +74.48% | +8.57% |
| 5-year return | +20.37% | -46.79% |
| P/E ratio (TTM) | 152.67 | — |
| Forward P/E | 18.32 | — |
| EPS (TTM) | $0.06 | $-0.24 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $989.71M | $197.14M |
| Revenue growth (YoY) | +15.93% | +34.28% |
| Net income (latest FY) | $-2.54M | $41.35M |
| Gross margin | 23.01% | 20.86% |
| Operating margin | 0.26% | -11.34% |
| Net margin | -0.26% | 20.97% |
| 52-week high | $12.64 | $6.50 |
| 52-week low | $4.70 | $3.95 |
| Distance from 52-week high | -27.53% | -29.85% |
| Analyst consensus | none | strong_buy |
| Avg. price target upside | +31.00% | +111.18% |
| Average volume | 595.71K | 982.75K |
| Shares outstanding | 136.46M | 89.32M |
| Employees | 2,500 | 327 |
| Sector | Health Care | Health Care |
| Industry | Medical/Nursing Services | Medical/Nursing Services |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- InnovAge is about 3.1 times larger than Strata Critical Medical by market value ($1.25B vs $407.30M).
- INNV has outperformed SRTA by 65.9 percentage points over the past year.
- Strata Critical Medical is more profitable, keeping 21.0 cents of every revenue dollar as net income versus -0.3 cents for InnovAge.
- Strata Critical Medical grew revenue faster in its latest fiscal year (+34.28% vs +15.93%).
About InnovAge
INNV stock →InnovAge Holding Corp. manages and provides a range of medical and ancillary services for seniors.
Health Care · Medical/Nursing Services · 2,500 employees
About Strata Critical Medical
SRTA stock →Strata Critical Medical, Inc. provides time-critical logistics and medical services to the healthcare industry in the United States.
Health Care · Medical/Nursing Services · 327 employees
INNV vs SRTA FAQ
Which is bigger, InnovAge or Strata Critical Medical?
InnovAge (INNV) is larger, with a market capitalization of $1.25B compared with $407.30M for Strata Critical Medical (SRTA).
Which stock has performed better over the past year, INNV or SRTA?
INNV returned +74.48% over the past 12 months, compared with +8.57% for SRTA (price return, excluding dividends). Past performance does not predict future results.
Are InnovAge and Strata Critical Medical in the same industry?
Yes. Both are classified in the Medical/Nursing Services industry within the Health Care sector.